The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring

Clin Diabetes. 2020 Oct;38(4):348-356. doi: 10.2337/cd19-0093.

Abstract

Continuous glucose monitoring (CGM) provides comprehensive assessment of daily glucose measurements for patients with diabetes and can reveal high and low blood glucose values that may occur even when a patient's A1C is adequately controlled. Among the measures captured by CGM, the percentage of time in the target glycemic range, or "time in range" (typically 70-180 mg/dL), has emerged as one of the strongest indicators of good glycemic control. This review examines the shift to using CGM to assess glycemic control and guide diabetes treatment decisions, with a focus on time in range as the key metric of glycemic control.

Associated data

  • figshare/10.2337/figshare.12245486